日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of symptomatic comorbidities on heatstroke outcomes: A retrospective nationwide cohort study

症状性合并症对中暑结局的影响:一项回顾性全国队列研究

Inukai, Koichi; Narikawa, Ryo; Kishitani, Suguru; Takeuchi, Takamasa; Takeda, Kentaro; Kaneko, Hiroyuki; Ikeda, Syuhei; Fukuda, Masahiro; Kato, Junichiro; Kittaka, Hirotada; Ito, Yusuke; Sawano, Hirotaka

Starvation ketoacidosis associated with tirzepatide use for weight loss in a non-diabetic East Asian woman: a case report

一例非糖尿病东亚女性因使用替唑帕肽减肥而发生饥饿性酮症酸中毒的病例报告

Minoda, Yuki; Ikeda, Syuhei; Inukai, Koichi; Kishitani, Suguru; Takeuchi, Takamasa; Aikawa, Hirohiko; Saito, Ken; Kittaka, Hirotada; Hayashi, Yasuyuki; Sawano, Hirotaka; Ito, Yusuke

Multiple Cranial Neuropathies After Lenvatinib-Pembrolizumab Therapy for Metastatic Renal Cell Carcinoma: A Case Report

转移性肾细胞癌患者接受乐伐替尼联合帕博利珠单抗治疗后出现多发性颅神经病变:病例报告

Minagawa, Hideyuki; Kaneko, Tomoyuki; Hokkoku, Keiichi; Miyashima, Ayano; Hazuki, Inoue; Tenei, Ono; Yagi, Risako; Kishitani, Kenjiro; Takei, Kazuki; Nakagawa, Tohru

Physical, but not laboratory, treatment-related adverse events are associated with favorable outcomes of enfortumab vedotin for advanced urothelial carcinoma: A landmark analysis

一项里程碑式分析表明,与治疗相关的生理不良事件(而非实验室不良事件)与恩福妥单抗治疗晚期尿路上皮癌的良好预后相关:

Taguchi, Satoru; Kawai, Taketo; Ambe, Yoshiki; Kishitani, Kenjiro; Noda, Michio; Kaneko, Tomoyuki; Miyakawa, Jimpei; Nakamura, Yu; Hoshina, Hayato; Obinata, Daisuke; Yamaguchi, Kenya; Kakutani, Shigenori; Furuya, Yoshitsune; Sato, Yujiro; Adachi, Yume; Sugimoto, Kazuma; Sato, Keigo; Tabata, Mariko; Tanaka, Takehiro; Nara, Katsuhiko; Uemura, Yukari; Kamei, Jun; Akiyama, Yoshiyuki; Sato, Yusuke; Yamada, Yuta; Niimi, Aya; Yamada, Daisuke; Takada, Tappei; Takahashi, Sayuri; Yamada, Yukio; Miyazaki, Hideyo; Enomoto, Yutaka; Nishimatsu, Hiroaki; Fujimura, Tetsuya; Fukuhara, Hiroshi; Nakagawa, Tohru; Takahashi, Satoru; Kume, Haruki

Survival improvement over time in renal cell carcinoma treated with nephrectomy: A longitudinal propensity score-matched study

肾切除术治疗肾细胞癌患者的生存率随时间推移而提高:一项纵向倾向评分匹配研究

Kishitani, Kenjiro; Taguchi, Satoru; Tanaka, Koji; Danno, Tetsuya; Oshina, Takahiro; Fujii, Yoichi; Kamei, Jun; Akiyama, Yoshiyuki; Kakutani, Shigenori; Sato, Yusuke; Yamada, Yuta; Niimi, Aya; Yamada, Daisuke; Kume, Haruki

Absence of the Susceptibility Vessel Sign with Cancer-Associated Hypercoagulability-Related Stroke

癌症相关高凝状态相关性卒中伴易感血管征缺失

Fukunaga, Daiki; Fujinami, Jun; Kishitani, Toru; Tokuda, Naoki; Numa, Soichiro; Nagakane, Yoshinari

Surgical resection of retinoblastoma-associated bladder leiomyosarcoma during pregnancy: a case report

妊娠期视网膜母细胞瘤相关膀胱平滑肌肉瘤的手术切除:病例报告

Hoshina, Hayato; Taguchi, Satoru; Suyama, Hikaru; Kishitani, Kenjiro; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Akiba, Naoya; Kumasawa, Keiichi; Mori-Uchino, Mayuyo; Osuga, Yutaka; Kume, Haruki

Left-right reversal of the testes within the scrotum: An extremely rare variant of testicular ectopia

睾丸在阴囊内左右颠倒:一种极其罕见的睾丸异位症

Kishitani, Kenjiro; Yoda, Kenji; Taguchi, Satoru; Suyama, Hikaru; Hoshina, Hayato; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Kume, Haruki

Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020)

提高晚期尿路上皮癌患者在真实世界中的生存率:一项多中心倾向评分匹配队列研究比较了帕博利珠单抗引入前(2003-2011 年)和近期(2016-2020 年)两个时期的生存率

Taguchi, Satoru; Kawai, Taketo; Nakagawa, Tohru; Miyakawa, Jimpei; Kishitani, Kenjiro; Sugimoto, Kazuma; Nakamura, Yu; Kamei, Jun; Obinata, Daisuke; Yamaguchi, Kenya; Kaneko, Tomoyuki; Yoshida, Kanae; Yamamoto, Sachi; Kakutani, Shigenori; Kanazawa, Koichiro; Sugihara, Yuriko; Tokunaga, Mayuko; Matsumoto, Akihiko; Uemura, Yukari; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Enomoto, Yutaka; Nishimatsu, Hiroaki; Ishikawa, Akira; Tanaka, Yoshinori; Nagase, Yasushi; Fujimura, Tetsuya; Fukuhara, Hiroshi; Takahashi, Satoru; Kume, Haruki

Comparison of full-dose gemcitabine/cisplatin, dose-reduced gemcitabine/cisplatin, and gemcitabine/carboplatin in real-world patients with advanced urothelial carcinoma

在真实世界中,比较全剂量吉西他滨/顺铂、减量吉西他滨/顺铂和吉西他滨/卡铂治疗晚期尿路上皮癌患者的疗效

Sugimoto, Kazuma; Taguchi, Satoru; Kishitani, Kenjiro; Kawai, Taketo; Masuda, Kazuki; Nakamura, Yu; Kinjo, Manami; Tambo, Mitsuhiro; Miyakawa, Jimpei; Akiyama, Yoshiyuki; Yamada, Yuta; Sato, Yusuke; Yamada, Daisuke; Nakagawa, Tohru; Fukuhara, Hiroshi; Kume, Haruki